Michelle Dawson posts

Post published on Twitter/X on 16 Aug 2022 05:45

Back to posts Previous post Next post
Twitter/X Clinical trial clinicaltrials.gov Extract quoted in the post Question asked by Dawson in the post External link integrated into the post Autism terms
Open original post

Information about the link integrated into the post

Clinical trial

Stanford University, National Institutes of Health (NIH) (2023). Trial of Diphenhydramine for Sleep in Children With Autism. ClinicalTrials.gov. Stanford University.

More information

Structured cited links

1 cited resource

Clinical trial Fetched Post clinicaltrials.gov

Stanford University, National Institutes of Health (NIH) (2023). Trial of Diphenhydramine for Sleep in Children With Autism. ClinicalTrials.gov. Stanford University.

Publication date
9 Aug 2023
Identifier
NCT05501678
Authors
Stanford University, National Institutes of Health (NIH)
Source
ClinicalTrials.gov
Reference type
clinical_trial
Publisher
Stanford University
Metadata source
clinicaltrials.gov

Abstract

The purpose of this study is to examine the effect of diphenhydramine on sleep in children and adolescents with Autism Spectrum Disorder (ASD). Diphenhydramine is an anti-histaminergic agent with strong hypnotic properties. To accomplish this, the investigators will use a randomized double-blind placebo-controlled crossover 8-week study design to examine the effect of diphenhydramine on sleep physiology as assessed by polysomnography (PSG), actigraphy, circadian rhythm, and clinical measures.

Open source Link to cited source